This comprehensive analysis examines Humana's current situation, future prospects, and the factors that could shape its performance in ... undervalued or overvalued stock lists.

Humana continues to face pressure from rising medical costs, and its benefits expense ratio increased by 270 bps y-o-y to 89%, weighing on its stock performance. Our detailed analysis of Humana ...

Market Capitalization Analysis: Falling below industry ... Revenue Growth: Over the 3M period, Humana showcased positive performance, achieving a revenue growth rate of 10.4% as of 31 December ...

InvestingPro analysis suggests the stock may be undervalued based on its comprehensive ... The ongoing Stars rating lawsuit presents a significant risk to Humana’s financial performance. If the ...

Humana (HUM) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Our detailed analysis of Humana’s upside post-inflation shock ... It compares these trends to the stock’s performance during the 2008 recession. In contrast, here’s how HUM stock and the ...

Humana's stock has declined ... business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results.

and buyers emerged Humana Inc.'s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something ...

This was the stock's second consecutive day of losses.

One of the country’s largest providers of private Medicare plans saw its stock sink to its ... for achieving 4- and 5- Star performance for many measures,” Humana said Wednesday in a statement ...

Humana Inc. closed 43.21% below its 52-week high of $406.46, which the company reached on July 18th.